In our study, we observed a mean decrease in muscle mass of 2.07% (SD = 8.74, SE Mean = 1.12), with a p -value of 0.06, indicating a trend towards significance.
← all excerpts
Oral Semaglutide in Type 2 Diabetes: Clinical-Metabolic Outcomes and Quality of Life in Real-World Practice.
1
—
—